CR20170157A - Derivados de nucleósidos sustituidos con 4´-vinilo como inhibidores de la replicación del arn del virus respiratorio sincitial - Google Patents
Derivados de nucleósidos sustituidos con 4´-vinilo como inhibidores de la replicación del arn del virus respiratorio sincitialInfo
- Publication number
- CR20170157A CR20170157A CR20170157A CR20170157A CR20170157A CR 20170157 A CR20170157 A CR 20170157A CR 20170157 A CR20170157 A CR 20170157A CR 20170157 A CR20170157 A CR 20170157A CR 20170157 A CR20170157 A CR 20170157A
- Authority
- CR
- Costa Rica
- Prior art keywords
- respiratory
- nucleosids
- replication
- rna
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/11—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/213—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Abstract
La solicitud da a conocer compuestos de fórmula I: en la que los sustituyentes variables son tal como se definen en el presente documento. Los compuestos de fórmula I y las composiciones farmacéuticas que comprenden compuestos de fórmula I son útiles para el tratamiento de enfermedades mediadas por VRS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462055704P | 2014-09-26 | 2014-09-26 | |
PCT/US2015/052144 WO2016049415A1 (en) | 2014-09-26 | 2015-09-25 | 4'-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus rna replication |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20170157A true CR20170157A (es) | 2017-07-03 |
Family
ID=55582038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20170157A CR20170157A (es) | 2014-09-26 | 2015-09-25 | Derivados de nucleósidos sustituidos con 4´-vinilo como inhibidores de la replicación del arn del virus respiratorio sincitial |
Country Status (20)
Country | Link |
---|---|
US (1) | US10358458B2 (es) |
EP (1) | EP3197457B1 (es) |
JP (1) | JP6671355B2 (es) |
KR (1) | KR102573609B1 (es) |
CN (1) | CN107073002B (es) |
AU (1) | AU2015320511B2 (es) |
BR (1) | BR112017006264A2 (es) |
CA (1) | CA2962770C (es) |
CL (1) | CL2017000707A1 (es) |
CO (1) | CO2017003994A2 (es) |
CR (1) | CR20170157A (es) |
EA (1) | EA031726B1 (es) |
IL (1) | IL251368B (es) |
MA (1) | MA40149A1 (es) |
MX (1) | MX2017003788A (es) |
PE (1) | PE20170698A1 (es) |
PH (1) | PH12017500558A1 (es) |
SG (2) | SG11201702430WA (es) |
WO (1) | WO2016049415A1 (es) |
ZA (1) | ZA201702858B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10358458B2 (en) | 2014-09-26 | 2019-07-23 | Riboscience Llc | 4′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication |
CA3134613A1 (en) * | 2019-04-02 | 2020-10-08 | Aligos Therapeutics, Inc. | Compounds targeting prmt5 |
WO2021155277A1 (en) * | 2020-01-31 | 2021-08-05 | Octagon Therapeutics, Inc. | Modulation of immune cells |
CN112194694B (zh) * | 2020-09-29 | 2022-03-25 | 佛山科学技术学院 | 尿苷酸双苯丙酸酯基氨基磷酸酯化合物、其药物组合物及其制备方法和应用 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU727177B2 (en) | 1996-10-16 | 2000-12-07 | Icn Pharmaceuticals, Inc. | Purine L-nucleosides, analogs and uses thereof |
KR20000070167A (ko) * | 1997-01-14 | 2000-11-25 | 와트 씨 데이빗, 해리 에이 루스제 | 질병의 시토킨 관련 치료 방법 |
EP1103559A1 (en) * | 1997-01-17 | 2001-05-30 | ICN Pharmaceuticals, Inc. | Autoimmune nucleosides |
UA72612C2 (en) * | 2000-07-06 | 2005-03-15 | Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells | |
GB0114286D0 (en) | 2001-06-12 | 2001-08-01 | Hoffmann La Roche | Nucleoside Derivatives |
WO2003026675A1 (en) | 2001-09-28 | 2003-04-03 | Idenix (Cayman) Limited | Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside |
JP2005504087A (ja) | 2001-09-28 | 2005-02-10 | イデニクス(ケイマン)リミテツド | 4’が修飾されたヌクレオシドを使用するc型肝炎ウイルス治療のための方法および組成物 |
TWI332507B (en) | 2002-11-19 | 2010-11-01 | Hoffmann La Roche | Antiviral nucleoside derivatives |
CA2514466C (en) * | 2003-02-19 | 2015-05-26 | Yale University | Anti-viral nucleoside analogs and methods for treating viral infections, especially hiv infections |
WO2005020885A2 (en) * | 2003-05-21 | 2005-03-10 | Isis Pharmaceuticals, Inc. | Compositions and methods for the treatment of severe acute respiratory syndrome (sars) |
CN101287472B (zh) | 2005-08-15 | 2011-10-12 | 弗·哈夫曼-拉罗切有限公司 | 抗病毒的4'-取代前核苷酸的氨基磷酸酯类化合物 |
WO2007145593A1 (en) | 2006-06-15 | 2007-12-21 | Jyoti Chattopadhyaya | Conformationally constrained 2' -n,4' -c-ethylene-bridged thymidine (aza-ena-t) |
WO2009064387A2 (en) | 2007-11-09 | 2009-05-22 | Gov't Of The U.S.A, As Represented By The Secretary, Department Of Health & Human Services | C4'-substituted-2-deoxyadenosine analogs and methods of treating hiv |
US8445669B2 (en) | 2008-04-10 | 2013-05-21 | Hamari Chemicals, Ltd. | Production process of ethynylthymidine compounds from 5-methyluridine as a starting material |
WO2010030858A1 (en) | 2008-09-15 | 2010-03-18 | Enanta Pharmaceuticals, Inc. | 4'-allene-substituted nucleoside derivatives |
US8927513B2 (en) | 2009-07-07 | 2015-01-06 | Alnylam Pharmaceuticals, Inc. | 5′ phosphate mimics |
WO2011133868A2 (en) | 2010-04-22 | 2011-10-27 | Alnylam Pharmaceuticals, Inc. | Conformationally restricted dinucleotide monomers and oligonucleotides |
US20130018011A1 (en) * | 2011-06-10 | 2013-01-17 | Hassan Javanbakht | Method of treating dengue fever |
DK2794627T3 (en) * | 2011-12-22 | 2019-01-14 | Alios Biopharma Inc | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGUES THEREOF |
CN106749272B (zh) | 2012-03-13 | 2019-08-30 | 吉利德科学公司 | 用于抗病毒治疗的2’-取代的卡巴-核苷类似物 |
PL2827875T3 (pl) | 2012-03-21 | 2019-07-31 | Janssen Biopharma, Inc. | Podstawione nukleozydy, nukleotydy i ich analogi |
US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
MX2015005500A (es) * | 2012-10-29 | 2016-02-09 | Cocrystal Pharma Inc | Nucleotidos de pirimidina y sus profarmacos de monofosfato para el tratamiento de infecciones virales y cancer. |
TW201542578A (zh) | 2013-06-26 | 2015-11-16 | Alios Biopharma Inc | 經取代之核苷、核苷酸及其類似物 |
AU2014331863C1 (en) * | 2013-10-11 | 2019-05-16 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
UA119050C2 (uk) | 2013-11-11 | 2019-04-25 | Ґілеад Саєнсиз, Інк. | ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ |
US9603864B2 (en) * | 2014-06-24 | 2017-03-28 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
WO2015200205A1 (en) | 2014-06-24 | 2015-12-30 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
TWI673283B (zh) * | 2014-08-21 | 2019-10-01 | 美商基利科學股份有限公司 | 2’-氯胺基嘧啶酮及嘧啶二酮核苷類 |
US10358458B2 (en) | 2014-09-26 | 2019-07-23 | Riboscience Llc | 4′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication |
-
2015
- 2015-09-25 US US14/865,135 patent/US10358458B2/en active Active
- 2015-09-25 MA MA40149A patent/MA40149A1/fr unknown
- 2015-09-25 KR KR1020177011174A patent/KR102573609B1/ko active IP Right Grant
- 2015-09-25 EA EA201790632A patent/EA031726B1/ru not_active IP Right Cessation
- 2015-09-25 SG SG11201702430WA patent/SG11201702430WA/en unknown
- 2015-09-25 PE PE2017000521A patent/PE20170698A1/es unknown
- 2015-09-25 BR BR112017006264A patent/BR112017006264A2/pt not_active IP Right Cessation
- 2015-09-25 SG SG10201810361TA patent/SG10201810361TA/en unknown
- 2015-09-25 CR CR20170157A patent/CR20170157A/es unknown
- 2015-09-25 AU AU2015320511A patent/AU2015320511B2/en active Active
- 2015-09-25 CA CA2962770A patent/CA2962770C/en active Active
- 2015-09-25 JP JP2017516420A patent/JP6671355B2/ja active Active
- 2015-09-25 CN CN201580055281.3A patent/CN107073002B/zh active Active
- 2015-09-25 MX MX2017003788A patent/MX2017003788A/es unknown
- 2015-09-25 WO PCT/US2015/052144 patent/WO2016049415A1/en active Application Filing
- 2015-09-25 EP EP15844391.1A patent/EP3197457B1/en active Active
-
2017
- 2017-03-23 IL IL251368A patent/IL251368B/en active IP Right Grant
- 2017-03-24 PH PH12017500558A patent/PH12017500558A1/en unknown
- 2017-03-24 CL CL2017000707A patent/CL2017000707A1/es unknown
- 2017-04-24 ZA ZA2017/02858A patent/ZA201702858B/en unknown
- 2017-04-25 CO CONC2017/0003994A patent/CO2017003994A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2962770A1 (en) | 2016-03-31 |
KR20170062499A (ko) | 2017-06-07 |
CN107073002B (zh) | 2019-10-15 |
ZA201702858B (en) | 2018-08-29 |
WO2016049415A1 (en) | 2016-03-31 |
EP3197457B1 (en) | 2022-11-09 |
SG10201810361TA (en) | 2018-12-28 |
NZ730923A (en) | 2020-09-25 |
EA031726B1 (ru) | 2019-02-28 |
BR112017006264A2 (pt) | 2017-12-12 |
CO2017003994A2 (es) | 2017-07-11 |
PE20170698A1 (es) | 2017-06-05 |
US20160264611A1 (en) | 2016-09-15 |
PH12017500558A1 (en) | 2017-08-30 |
IL251368A0 (en) | 2017-05-29 |
EP3197457A4 (en) | 2018-08-01 |
JP6671355B2 (ja) | 2020-03-25 |
CL2017000707A1 (es) | 2017-12-15 |
KR102573609B1 (ko) | 2023-08-31 |
SG11201702430WA (en) | 2017-04-27 |
MA40149A1 (fr) | 2019-04-30 |
CA2962770C (en) | 2023-08-22 |
CN107073002A (zh) | 2017-08-18 |
US10358458B2 (en) | 2019-07-23 |
IL251368B (en) | 2020-05-31 |
AU2015320511A1 (en) | 2017-05-04 |
EA201790632A1 (ru) | 2017-09-29 |
AU2015320511B2 (en) | 2020-11-12 |
JP2017529375A (ja) | 2017-10-05 |
EP3197457A1 (en) | 2017-08-02 |
MX2017003788A (es) | 2017-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018001685A1 (es) | Compuestos heterociclicos como inmuno moduladores. | |
ECSP20033467A (es) | Compuestos macrocíclicos para tratar enfermedades | |
CO2017006962A2 (es) | Derivados de 2-anilinopirimidina sustituida como moudladores de egfr | |
NI201600115A (es) | Derivados de sulfamoilpirrolamida y su uso como medicamentos para el tratamiento de la hepatitis b. | |
CR20160237A (es) | Derivados de la carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
CR20160518A (es) | Compuestos para tratar atrofia muscular espinal | |
CO2017001884A2 (es) | Polimorfos de selinexor | |
UA116648C2 (uk) | Фумарати як проліки та їх застосування при лікуванні різних захворювань | |
CO6781507A2 (es) | Novedosos derivados heterociclicos | |
CU20190101A7 (es) | Imidazopirimidinas diazabicíclicas sustituidas | |
UY36702A (es) | Piridinas sustituidas y métodos de uso | |
DOP2017000034A (es) | Compuestos de imidazopiridazina | |
EA201591406A1 (ru) | C-19 модифицированные тритерпеноиды с ингибиторной активностью созревания вич | |
CO2018007278A2 (es) | Derivados de ácido aminobenzoico metaazacíclico como antagonistas de la integrina pan | |
CO2017007325A2 (es) | 2,4 diamino-quinolina sustituida como nuevos agentes anti-cancerigenos | |
DOP2017000064A (es) | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos | |
CU20160140A7 (es) | CROMENE Y 1,1 A,2,7B- tetrahidrociclopropa[C]CROMENE PIRIDOPIRAZINEDIONES COMO MODULADORES DE GAMMA-SECRETASA | |
UY36070A (es) | Triterpenoides con actividad inhibidora de la maduración de hiv | |
UY36145A (es) | Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer | |
CO2017000011A2 (es) | Derivados de quinolizinona como inhibidores de pi3k | |
UY35997A (es) | Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
CR20160448A (es) | Nuevos derivados de piridina | |
CL2018001493A1 (es) | Nuevos derivados de fenilo | |
UY37729A (es) | NUEVOS COMPUESTOS QUE INHIBEN LA ACTIVIDAD DE Nav1.7 | |
CO2017003994A2 (es) | Derivados de nucleósidos sustituidos con 4’-vinilo como inhibidores de la replicación del arn del virus respiratorio sincitial |